FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Transiderm-Nitro 10 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Doncaster Pharmaceuticals Ltd) 30 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Doncaster Pharmaceuticals Ltd) 30 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 100 patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 100micrograms/24hours patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 37.5micrograms/24hours patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 100 patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Sigma Pharmaceuticals Plc) 28 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Sigma Pharmaceuticals Plc) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 5 transdermal patches (Sigma Pharmaceuticals Plc) 30 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Sigma Pharmaceuticals Plc) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 100micrograms/24hours patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 37.5micrograms/24hours patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Sigma Pharmaceuticals Plc) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Sigma Pharmaceuticals Plc) 30 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Sigma Pharmaceuticals Plc) 30 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 25mg/16hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 25mg/16hours patches (McNeil Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 15mg/16hours patches (McNeil Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 10mg/16hours patches (McNeil Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 25mg/16hours transdermal patches 7 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 25mg/16hours patches (McNeil Ltd) 7 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 10mg/16hours patches (McNeil Ltd) 7 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 15mg/16hours patches (McNeil Ltd) 7 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour patches (Actavis UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour patches (Actavis UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour patches (Actavis UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour patches (Actavis UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour patches (Actavis UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour patches (Actavis UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour patches (Actavis UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour patches (Actavis UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Novartis Pharmaceuticals UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patches 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (PI) (Dowelhurst Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (PI) (Dowelhurst Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Sigma Pharmaceuticals Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (PI) (Waymade Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Novartis Pharmaceuticals UK Ltd) 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (PI) (Waymade Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Doncaster Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 5micrograms/hour patches 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 5micrograms/hour patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicopatch 14mg/24hours transdermal patches (Pierre Fabre Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotinell TTS 20 patches (Haleon UK Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotinell TTS 20 patches (Haleon UK Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
NiQuitin CQ Clear 14mg patches (GlaxoSmithKline Consumer Healthcare) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
NiQuitin Clear 14mg patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
NiQuitin CQ 14mg patches (GlaxoSmithKline Consumer Healthcare) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots Nicotine 14mg/24 hours patches (The Boots Company) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 14mg/24hours patches 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
NiQuitin CQ Clear 14mg patches (GlaxoSmithKline Consumer Healthcare) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotinell TTS 20 patches (Haleon UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 14mg/24hours patches 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 14mg/24hours patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots Nicotine 14mg/24 hours patches (The Boots Company) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicopatch 14mg/24hours transdermal patches (Pierre Fabre Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
NiQuitin CQ 14mg patches (GlaxoSmithKline Consumer Healthcare) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
NiQuitin Clear 14mg patches (Waymade Healthcare Plc) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 75 patches (Merck Pharmaceuticals) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 75 patches (Norgine Pharmaceuticals Ltd) 24 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 6 of 21 Next End

This concept is not in any reference sets

Back to Start